1. Oxaliplatin- versus cisplatin-based regimens for elderly individuals with advanced gastric cancer: a retrospective cohort study
   Takashi Chinen et al, 2022, BMC Cancer CrossRef
2. Zolbetuximab: An Investigational First-Line Treatment for CLDN18.2-positive, HER2-negative Gastric and Gastro-oesophageal Junction Cancer
   Joud Al Karmi et al, 2023, Oncology & Haematology CrossRef
3. The critical role of circular RNAs in drug resistance in gastrointestinal cancers
   Sadra Samavarchi Tehrani et al, 2023, Medical Oncology CrossRef
4. Treatment patterns, healthcare resource utilization and costs of HER2-negative gastric/gastroesophageal junction cancer
   Rupali Fuldeore et al, 2023, Future Oncology CrossRef
5. Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers
   Adel Shahnam et al, 2023, Gastrointestinal Tumors CrossRef
6. Prevalence and Prognostic Value of Malnutrition Among Elderly Cancer Patients Using Three Scoring Systems
   Qi Zhang et al, 2021, Frontiers in Nutrition CrossRef
7. Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinoma
   Kohei Shitara et al, 2023, Cancer Science CrossRef